Transplantology
![](uploads/services/5b601451e4376.png)
Liver Transplantation
What are living donor liver transplants?
Who needs a liver transplant?
Our hospital’s advantages:
- High-tech liver ICU
- New infrastructure and comfortable environment
- Up-to-date treatment approaches and technologies
- Latest technology and facilities
- ISO 9001:2015 certified clinical laboratory
- Well-trained, experienced and dedicated doctors and para-medical staff
- Patient-centered and safe medical care
Who can be a liver donor?
Stages of liver transplant operation
- Pre-operative care (consultations, lab and imaging studies are conducted during this period)
- Transplant operation
- Post-operative care
Pediatric Kidney Transplantation
The uronephrology department at M. Iashvili Children’s Central Hospital offers a new, innovative service – kidney transplantation. In modern medicine kidney transplantation represents the treatment of choice for end-stage kidney disease management. After successful transplantation the patient is no longer dependent on dialysis, quality of life improves and the normal rhythm of daily life can be resumed.
In addition, the hospital offers 24-hour high quality diagnostic services: blood biochemistry; bacteriology laboratory; renal ultrasound with colorized Doppler; biopsy of native kidney and allotransplant with ultrasound-Doppler control; various radiologic studies; and consultations with different specialists.
Uronephrology department provides a wide range of management options for various pathologies in renal and urinary excretory systems, both medical and surgical options; minimally invasive interventions with laparoscopy; renal replacement with hemodialysis and peritoneal dialysis.
Adult Kidney Transplantation
Bone Marrow Transplantation
- A physical examination of patient and general state of health;
- Stimulation and mobilization stem cells which be use at the process of transplantation;
- Preparing the patient for the transplant (known as conditioning);
- Transplanting the stem cells;
- The recovery period, during which patient will be monitored for 100 days (in sterile room about 30 days) for any side effects and complications.
- Leukemia;
- Lymphoma (HDL, HL);
- Multiple myeloma (MM);
- Hereditary blood disorders (thalassemia e.t.c);
- Acquired blood disorders (SAA e.t.c);
- Solid tumors;
- Genetic disorder of metabolism.
-
Patient with complete remission;
-
Patient with partial remission;
-
The associated condition is not responding to other forms of treatment or it is felt that there is a high risk of the condition returning without a transplant;
-
Hereditary disorders disease progression if the patient has compatible donor.